Pharmacokinetics of nicotinamide and its effect on blood pressure, pulse and body temperature in normal human volunteers
- PMID: 1410588
- DOI: 10.1016/0167-8140(92)90193-x
Pharmacokinetics of nicotinamide and its effect on blood pressure, pulse and body temperature in normal human volunteers
Abstract
The pharmacokinetics of nicotinamide were studied in four human volunteers after oral doses of 1-6 g. Plasma concentrations and clearance rates of the vitamin were found to be dose-dependent, with a half-life of approximately 7-9 h for the two highest doses administered (4 and 6 g), approximately 4 h with 2 g and approximately 1.5 h with a 1-g dose. Peak concentrations ranged from 0.7 to 1.1 mumol.ml-1 after a 6-g dose. The time to reach peak plasma concentration was dose independent with a broad range from 0.73 to 3 h. In this study, nicotinamide had no detectable effect on blood pressure, pulse or body temperature.
Similar articles
-
Pharmacokinetics of varying doses of nicotinamide and tumour radiosensitisation with carbogen and nicotinamide: clinical considerations.Br J Cancer. 1993 Dec;68(6):1115-21. doi: 10.1038/bjc.1993.490. Br J Cancer. 1993. PMID: 8260362 Free PMC article.
-
Pharmacokinetics of nicotinamide in cancer patients treated with accelerated radiotherapy: the experience of the Co-operative Group of Radiotherapy of the European Organization for Research and Treatment of Cancer.Radiother Oncol. 1998 Aug;48(2):123-33. doi: 10.1016/s0167-8140(98)00048-6. Radiother Oncol. 1998. PMID: 9783883 Clinical Trial.
-
Pharmacokinetics and biochemistry studies on nicotinamide in the mouse.Cancer Chemother Pharmacol. 1994;34(5):399-404. doi: 10.1007/BF00685564. Cancer Chemother Pharmacol. 1994. PMID: 8070006
-
Pharmacokinetics and tolerance of nicotinamide combined with radiation therapy in patients with glioblastoma multiforme.Acta Oncol. 1994;33(8):969-73. doi: 10.3109/02841869409098465. Acta Oncol. 1994. PMID: 7818933
-
Nicotinamide pharmacokinetics in humans and mice: a comparative assessment and the implications for radiotherapy.Radiother Oncol. 1993 May;27(2):131-9. doi: 10.1016/0167-8140(93)90133-s. Radiother Oncol. 1993. PMID: 8356223
Cited by
-
Carbogen breathing with nicotinamide improves the oxygen status of tumours in patients.Br J Cancer. 1995 Jul;72(1):198-205. doi: 10.1038/bjc.1995.303. Br J Cancer. 1995. PMID: 7599052 Free PMC article.
-
Extracellular vesicle encapsulated nicotinamide delivered via a trans-scleral route provides retinal ganglion cell neuroprotection.Acta Neuropathol Commun. 2024 Apr 22;12(1):65. doi: 10.1186/s40478-024-01777-0. Acta Neuropathol Commun. 2024. PMID: 38649962 Free PMC article.
-
Association between Daily Niacin Intake and Glaucoma: National Health and Nutrition Examination Survey.Nutrients. 2021 Nov 26;13(12):4263. doi: 10.3390/nu13124263. Nutrients. 2021. PMID: 34959814 Free PMC article.
-
Pharmacokinetics of varying doses of nicotinamide and tumour radiosensitisation with carbogen and nicotinamide: clinical considerations.Br J Cancer. 1993 Dec;68(6):1115-21. doi: 10.1038/bjc.1993.490. Br J Cancer. 1993. PMID: 8260362 Free PMC article.
-
C/EBPε mediates nicotinamide-enhanced clearance of Staphylococcus aureus in mice.J Clin Invest. 2012 Sep;122(9):3316-29. doi: 10.1172/JCI62070. Epub 2012 Aug 27. J Clin Invest. 2012. PMID: 22922257 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources